[Effect of serum proteins on the inhibition of adenosine permeability of human- and canine-erythrocyte membranes by 2,6-bis(diethanolamino)-4,8-dipiperidino-pyrimido-5,4-d-pyrimidine].
D000818:Animals; D001798:Blood Proteins / Q000008:administration & dosage / Q000494:pharmacology*; D002463:Cell Membrane Permeability / Q000187:drug effects*; D004285:Dogs; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism*; D006023:Glycoproteins / Q000494:pharmacology; D006801:Humans; D009705:Nucleosides / Q000032:analysis / Q000378:metabolism*; D010880:Piperidines / Q000494:pharmacology*; D011743:Pyrimidines / Q000494:pharmacology*; D013045:Species Specificity
D001798:Blood Proteins; D006023:Glycoproteins; D009705:Nucleosides; D010880:Piperidines; D011743:Pyrimidines
Der Einfluss von Serumproteinen auf die Hemmung der Adenosin-Permeabilität von Menschen- und Hunde-Erythrocytenmembranen durch 2,6-Bis(diäthanolamino)-4,8-dipiperidino-pyrimido-5,4-d-pyrimidin.